Preparation and application of dual-drive nano motor based on polymer vesicles

Through bowl-shaped polymer vesicles loaded with alumina and gold nanoparticles, the H2O2/laser dual drive is used to achieve efficient movement and photothermal therapy of nanomotors in the tumor, solving the large size and photothermal conversion in the prior art. The problems of low efficiency and limited treatment range improve the effectiveness of tumor treatment and reduce skin damage.

CN118903010APending Publication Date: 2024-11-08DONGHUA UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410886414.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-03
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing nanomotors have problems in tumor treatment, such as large size, low photothermal conversion efficiency and limited treatment range, especially in the tumor microenvironment, which leads to poor treatment effect and high temperature caused by local laser irradiation. It can cause skin damage and tumor recurrence.

Method used

Stomatocytes with asymmetric structures are used to simultaneously load ceria nanoparticles and gold nanoparticles. Through dual drive of H2O2/laser, a dual drive nanomotor is built to achieve autonomous movement and perform photothermal therapy inside the tumor. Relieves skin damage and relieves tumor hypoxia and inflammatory responses through loaded CeO2.

Benefits of technology

The efficient movement and photothermal treatment of nanomotors within the tumor are achieved, which enhances the therapeutic effect, reduces skin damage, and regulates the inflammatory response through CeO2, improving the safety and efficacy of treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903010A_ABST
    Figure CN118903010A_ABST
Patent Text Reader

Abstract

The invention relates to preparation and application of a dual-drive nano motor based on a polymer vesicle. The nano motor is a polymer vesicle loaded with cerium dioxide nanoparticles / gold nanoparticles or a polymer vesicle which is coated by a cell membrane and loaded with cerium dioxide nanoparticles / gold nanoparticles. The method is simple in preparation process, the product is easy to purify and separate, and the conversion prospect is good; the bowl-shaped polymer vesicle integrating a cancer cell membrane, cerium dioxide nanoparticles and gold nanoparticles can be used as a nano motor, and is driven by H2O2 / laser, so that movement-enhanced tumor photo-thermal therapy is realized, damage of photo-thermal to surface skin is relieved, and a new thought is provided for promoting diffusion of nano-drugs in tumors so as to realize more efficient tumor therapy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine, and in particular relates to the preparation and application of a dual-drive nanomotor based on polymer vesicles. Background Art

[0002] The complex tumor microenvironment (TME) often blocks the diffusion and penetration of "unpowered" nanomedicines in tumors, thereby affecting the therapeutic effect. In recent years, nanomotors that can convert external energy or chemical signals into mechanical kinetic energy have become one of the most promising anti-tumor nanoplatforms due to their autonomous movement capabilities. A variety of nanomotors, including light-driven nanomotors (Brongersma et al. Nat. Nanotechnol., 2015, 10 (1), 25-34), bubble-driven nanomotors (Liu et al. J. Am. Chem. Soc., 2022, 144 (9), 3892-3901) and glucose-assisted bimetallic nanomotors (Kwon et al. Angew. Chem., Int. Ed., 2021, 60 (32), 17579-17586) have been designed and developed. Among them, nanomotors that can convert laser energy into heat and further driven by thermophoresis have been used for intracellular drug delivery and tissue penetration due to their good motion performance (Zhang et al. Sci. Robot., 2022, 7, eabo4160). Considering the photothermal properties of gold (Au), combining different forms of Au with nanocarriers can construct thermophoretic nanomotors (Shao et al. J. Am. Chem. Soc., 2022, 144 (25), 11246-11252). However, most of the Au sizes in these nanomotors are larger than 10nm, which is not conducive to maximizing the photothermal conversion efficiency of Au. In addition, smaller Au is easier to achieve controllable spatial distribution on nanomotors.

[0003] Anisotropic bowl-shaped polymersomes (also called Stomatocytes because of their morphology similar to stomatocysts) have an asymmetric streamlined structure and can move in a directional manner under the impetus of external stimuli. They are an ideal nanomotor substrate platform (Pijpers et al. Nano Lett., 2020, 20(6), 4472-4480). Studies have shown that Stomatocytes (Au-Stomatocytes) coated with Au on the surface can utilize the photothermal properties of Au to perform directional thermophoresis under laser irradiation (Wang et al. Nat. Commun., 2024, 15, 4878). However, the potential of this Au-Stomatocyte in tumor treatment has not been fully developed. By activating the photothermal properties of Au in Au-Stomatocytes through laser irradiation, not only can photothermal therapy (PTT) be directly performed on tumors, but also the distribution of Au-Stomatocytes in tumors can be improved through thermophoresis, thereby enhancing the efficacy of PTT. In addition, except for the surface coating of nanoparticles, the internal cavity of Stomatocytes is not fully utilized, which limits the therapeutic application range of Stomatocytes.

[0004] When performing PTT on tumors, the high temperature caused by local laser irradiation will cause most tumor cells to necrotize, and the necrotic cells will induce an inflammatory response and trigger a cytokine storm, causing severe damage to the skin in the irradiated area and making the tumor prone to recurrence and metastasis (Boopathi et al. Int. J. Mol. Sci., 2021, 22(18), 10126). Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide a preparation and application of a dual-drive nanomotor based on polymer vesicles. The present invention uses bowl-shaped polymer vesicles Stomatocytes with an asymmetric structure to load cerium dioxide nanoparticles and gold nanoparticles to construct a dual-drive nanomotor, which can be driven by H2O2 / laser, so that it can penetrate deep into the tumor through autonomous movement to perform PTT and alleviate skin damage after PTT, thereby achieving effective treatment of tumors.

[0006] The invention provides a nano motor composite material. The nano motor is a polymer vesicle loaded with cerium dioxide nanoparticles / gold nanoparticles, or a cell membrane-coated polymer vesicle loaded with cerium dioxide nanoparticles / gold nanoparticles.

[0007] Preferably, the polymer vesicle is a bowl-shaped polymer vesicle; and the cell membrane is the cell membrane of mouse breast cancer 4T1 cells.

[0008] The present invention provides a method for preparing a nanomotor composite material, comprising:

[0009] (1) The copolymer PEG 22 -PDLLA 95 PEG 44 -PDLLA 95 , and an organic solvent, and then dropwise add water to obtain a polymersomes dispersion, and dialyze to obtain a bowl-shaped polymersomes dispersion;

[0010] (2) adding the cerium dioxide nanoparticle dispersion dropwise into the stomatocytes dispersion, stirring for reaction, and centrifuging to obtain a polymer vesicle Ce-Stomatocytes dispersion loaded with cerium dioxide nanoparticles;

[0011] (3) uniformly mixing chloroauric acid, polyacrylic acid and Ce-Stomatocytes dispersion, dropping a reducing agent, stirring for reaction, and centrifuging to obtain polymer vesicles Ce / Au-Stomatocytes loaded with cerium dioxide nanoparticles / gold nanoparticles;

[0012] (4) or the Ce / Au-Stomatocytes dispersion of step (3) is evenly mixed with the cell membrane suspension, extruded, and centrifuged to obtain cell membrane-coated polymer vesicles loaded with cerium dioxide nanoparticles / gold nanoparticles.

[0013] Preferably, the mixing in step (1) is to mix the two copolymers PEG 22 -PDLLA 95 and PEG 44 -PDLLA 95 Dissolve in an organic solution and stir evenly; the water is ultrapure water.

[0014] Preferably, in step (1), the copolymer PEG 22 -PDLLA 95 and PEG 44 -PDLLA 95 It is obtained by ring-opening polymerization using methoxypolyethylene glycol hydroxyl (mPEG-OH) and D,L-lactide (DLL) as raw materials.

[0015] In the step (1), the polymersomes are PEG 22 -PDLLA 95 and PEG 44 -PDLLA95 As raw materials, the two copolymers were self-assembled by solvent exchange method.

[0016] Preferably, in step (1), PEG 22 -PDLLA 95 PEG 44 -PDLLA 95 , the ratio of the organic solvent is 1 mg: 0.9 mg: 0.1 mL to 1 mg: 1.1 mg: 0.3 mL; the organic solvent is a mixed solution of tetrahydrofuran and dioxane; the volume ratio of tetrahydrofuran and dioxane is 1:3 to 1:5; the volume ratio of the organic solvent to water is 1:0.5 to 1:1.5; the rate of adding water is 0.5 to 1.5 mL / h.

[0017] Preferably, the dialysis in step (1) is performed using a dialysis bag with a molecular weight cutoff of 12-14 kDa in a precooled sodium chloride solution, the sodium chloride solution is replaced after 0.5-1.5 hours, and the dialysis is continued for 20-25 hours; wherein the concentration of the sodium chloride solution is 45-55 mM mM; and the dialysis temperature is 3-5°C.

[0018] Preferably, the cerium dioxide nanoparticle dispersion in step (2) is obtained by precipitation reaction using cerium nitrate hexahydrate, ammonia water and polyacrylic acid as raw materials.

[0019] Preferably, in the step (2), the mass ratio of cerium dioxide nanoparticles to stomatocytes is 2:0.5 to 2:1.5; the stirring reaction time is 20 to 25 hours; the centrifugation parameters are: centrifugation at 5500 to 6500 rpm for 5 to 10 minutes, and removing the supernatant.

[0020] Preferably, in the step (3), the mass ratio of polyacrylic acid, chloroauric acid and Ce-Stomatocytes is 0.24:0.00035:0.9-0.24:0.00037:1.1; the reducing agent is sodium borohydride solution with a concentration of 4-6 mM, and the volume ratio of Ce-Stomatocytes dispersion to sodium borohydride solution is 1:0.5-1:1.5; the stirring reaction time is 5-15 min; the centrifugation parameters are: centrifugation at 6500-7500 rpm for 5-15 min, and removing the supernatant.

[0021] Preferably, in the step (4), the ratio of Ce / Au-Stomatocytes to cell membrane suspension is 200 μg: 0.4 mL to 200 μg: 0.6 mL; the cell membrane is the cell membrane of breast cancer 4T1 cells; and the specific process of extrusion is: using an Avanti micro-extruder with a filter membrane pore size of 700 to 900 nm to repeatedly extrude 10 to 12 times.

[0022] The present invention provides an application of the nanomotor composite material in preparing motion-enhanced tumor photothermal therapy drugs.

[0023] The present invention uses Stomatocytes with an asymmetric structure as the base platform, and constructs a dual-drive nanomotor by simultaneously loading gold nanoparticles (Au NPs) with photothermal properties and cerium dioxide nanoparticles (CeO2 NPs) with enzyme-like activity. After further biomimetic treatment of cancer cell membranes, the nanomotor can actively accumulate in the tumor, and then be driven by H2O2 and laser to achieve motion-enhanced tumor PTT and regulate the inflammatory response after photothermal treatment, providing a new idea for improving the distribution of nanomedicines in solid tumors. Literature search found that there is currently no precedent for the use of dual-drive nanomotors with cell membrane biomimetic treatment for efficient tumor treatment, which highlights the innovation and uniqueness of this patent.

[0024] The present invention relates to the preparation of bowl-shaped polymer vesicles loaded with cerium dioxide nanoparticles / gold nanoparticles, the extraction of cancer cell membranes, and the preparation of bowl-shaped polymer vesicles with biomimetic camouflage of cancer cell membranes. The method has a simple preparation process, and the product is easy to purify and separate, and has good application transformation prospects; the bowl-shaped polymer vesicles integrating cancer cell membranes, cerium dioxide nanoparticles and gold nanoparticles can be used as nanomotors, driven by H2O2 / laser, to perform motion-enhanced tumor PTT and alleviate photothermal damage to the surface skin, providing a new idea for promoting the diffusion of nanomedicines in tumors to achieve more efficient tumor treatment.

[0025] In the present invention, Stomatocytes with an asymmetric structure are prepared by solvent exchange and dialysis-induced deformation method, and CeO2 NPs are loaded in the internal cavity and AuNPs are loaded on the surface by in situ reduction. Finally, the mouse breast cancer 4T1 cell membrane is coated on the surface of Stomatocytes by physical extrusion to obtain a dual-drive nanomotor for motion-enhanced tumor PTT.

[0026] The present invention uses Stomatocytes as a platform to integrate two different functional nanoparticles and cancer cell membranes. The dual-drive nanomotor constructed can not only drive non-directional motion by decomposing H2O2 to produce O2 bubbles, but also be driven by laser irradiation for directional motion. After biomimetic treatment through the cancer cell membrane, Stomatocytes can actively target the tumor area, and then penetrate into the deep layer of the tumor with the assistance of lasers, and implement PTT to effectively inhibit tumor growth. Finally, Stomatocytes can also use the loaded Ce to relieve tumor hypoxia and inhibit the inflammatory response after PTT, thereby further enhancing the efficacy of PTT and alleviating skin damage at the laser site. The present invention uses cryo-transmission electron microscopy (cryo-TEM) and dynamic light scattering analysis (DLS) to characterize the morphology and size of prepared Ce / Au-Stomatocytes; uses ultraviolet visible absorption spectrum (UV-vis) and SOD enzyme detection kit to evaluate the enzyme-like activity of prepared Ce / Au-Stomatocytes; analyzes the photothermal performance of Ce / Au-Stomatocytes by recording the temperature rise curve of Ce / Au-Stomatocytes under laser irradiation; analyzes the movement performance of Ce / Au-Stomatocytes by NanoSight Tracking Analysis (NTA); uses flow cytometry to detect the phagocytosis of cells on different Stomatocytes; uses CCK-8 method to analyze the cytotoxicity of Stomatocytes under different conditions; uses flow cytometry to evaluate the efficiency of Stomatocytes in inducing cancer cell apoptosis under different conditions; analyzes the in vivo distribution and tumor penetration of Stomatocytes under different conditions by fluorescence imaging in mice; finally, establishes a subcutaneous tumor model in mice for anti-tumor experiments.

[0027] Beneficial Effects

[0028] (1) The preparation process of Stomatocytes in the present invention is simple, the product is easy to purify and separate, and has good application prospects.

[0029] (2) The dual-drive nanomotor prepared in the present invention obtains photothermal performance and motion characteristics through Au NPs loaded on the surface, and can move autonomously under laser irradiation, thereby entering the tumor to implement PTT.

[0030] (3) The dual-drive nanomotor prepared in the present invention acquires enzyme-like activity through the loaded CeO2 NPs, which can not only generate O2 in the TME to drive movement and relieve tumor hypoxia, but also scavenge reactive oxygen species to regulate the level of inflammation after PTT.

[0031] (4) After the dual-drive nanomotor prepared by the present invention is injected into tumor-bearing mice through the tail vein, it can aggregate at the tumor site through homologous targeting, and then penetrate the tumor under laser irradiation to perform PTT, while regulating the inflammatory response to alleviate the damage of photothermal to the surface skin, which has potential clinical application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 Schematic diagram of the synthesis and application of Ce / Au-Stomatocytes@CM prepared in the present invention;

[0033] Figure 2 The photographs and hydrodynamic diameters of the Polymersomes dispersion (A) prepared in Comparative Example 1 and the Stomatocytes dispersion (B) prepared in Example 1; the cryo-TEM image of Stomatocytes (C);

[0034] Figure 3 The photographs, hydrodynamic diameters and cryo-TEM images of the Ce-Stomatocytes dispersion (AC) and Ce / Au-Stomatocytes dispersion (DF) prepared in Example 1;

[0035] Figure 4 Photos of Ce-Stomatocytes, Ce / Au-Stomatocytes, and CeO2 NPs ([Ce] = 5 mg / mL) dispersed in H2O2 solution (100 μM) at different time points (A) and the degradation of Ce-Stomatocytes, Ce / Au-Stomatocytes, and CeO2 NPs ([Ce] = 5 mg / mL) after incubation with H2O2 solutions of different concentrations for 10 min (B);

[0036] Figure 5 Degradation of H2O2 solution (100 μM) after incubation with Ce / Au-Stomatocytes of different concentrations for 15 min (A), degradation of Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) after incubation with Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) at different pH values ​​for 10 min (B), and degradation of Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) after incubation with Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) at different temperatures for 10 min (C); Figure 6The SOD-like enzyme activities of CeO2 NPs, Ce-Stomatocytes, Au-Stomatocytes, and Ce / Au-Stomatocytes ([Ce] = 2 mg / mL, A) and the SOD-like enzyme activities of Ce / Au-Stomatocytes at different Ce concentrations (B), different pH values ​​([Ce] = 2 mg / mL, C), and different temperatures ([Ce] = 2 mg / mL, D);

[0037] Figure 7 The ·OH scavenging efficiency of CeO2 NPs, Ce-Stomatocytes, Au-Stomatocytes, and Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) (A) and the ·OH scavenging efficiency of Ce / Au-Stomatocytes at different Ce concentrations (B) and different temperatures ([Ce] = 2 mg / mL, C);

[0038] Figure 8 Photothermal temperature rise curves of Ce / Au-Stomatocytes dispersions with different concentrations and control materials after laser irradiation (1.5W) (A), photothermal temperature rise curves of Ce / Au-Stomatocytes dispersions (3mg / mL) after laser irradiation with different powers (B), and temperature change curve of Ce / Au-Stomatocytes dispersions (3mg / mL) during cyclic laser irradiation (C); Fig. 9 Mean square displacement (A) and particle motion trajectory (D) of Ce / Au-Stomatocytes (10μg / mL) driven by lasers of different powers, MSD (B) of Ce / Au-Stomatocytes (10μg / mL) dispersed in H2O2 solution (100μM or 1mM) and particle motion trajectory when the H2O2 solution concentration is 100μM (E), MSD (C) of Ce / Au-Stomatocytes (10μg / mL) dispersed in water or H2O2 solution (100μM) driven by 1.25W or 1.5W laser, and particle motion trajectory (F) of Ce / Au-Stomatocytes (10μg / mL) dispersed in H2O2 solution (100μM) driven by 1.5W laser;

[0039] Fig.10 is a cryo-TEM image of Ce / Au-Stomatocytes@CM prepared in Example 8;

[0040] Fig.11 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) images of CM, Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM;

[0041] Fig.12 Flow cytometric analysis (A) and quantitative analysis (B) of intracellular fluorescence intensity of 4T1 cells treated with Stomatocytes, Ce-Stomatocytes, Ce / Au-Stomatocytes, and Ce / Au-Stomatocytes+Laser ([Stomatocytes]=50μg / mL) for 6h;

[0042] Fig.13 Flow cytometric analysis (A) and quantitative analysis (B) of intracellular fluorescence intensity of 4T1 cells or B16-F10 cells treated with Ce / Au-Stomatocytes, Ce / Au-Stomatocytes@CM, and Ce / Au-Stomatocytes@CM+Laser ([Stomatocytes]=50μg / mL) for 6h;

[0043] Fig.14 Cell viability graphs of Stomatocytes (A) or CeO2 NPs (B) after co-incubation with 4T1 cells for 24 hours, and cell viability graphs of Ce-Stomatocytes, Ce / Au-Stomatocytes, and Ce / Au-Stomatocytes@CM after co-incubation with 4T1 cells for 24 hours with or without laser irradiation (C);

[0044] Fig.15 Figure 4 shows the flow cytometry analysis of 4T1 cell apoptosis before and after treatment with different stomatocytes ([Stomatocytes] = 50 μg / mL) and laser (A), apoptosis rate (B), and necrosis rate (C);

[0045] Fig.16 The levels of IL-6 (A) and TNF-α (B) expressed by RAW264.7 cells before and after treatment with different stomatocytes ([Stomatocytes] = 50 μg / mL) and laser (Sto stands for stomatocytes);

[0046] Fig.17In vivo fluorescence imaging of tumor-bearing mice at different time points after injection of different Stomatocytes ([Stomatocytes] = 25 mg / kg) (A) and quantitative analysis of fluorescence intensity at tumor sites (C); in vitro fluorescence imaging of major organs and tumors 120 minutes after injection (B) and quantitative analysis of fluorescence intensity (D) (I: Au-Stomatocytes, II: Au-Stomatocytes@CM, III: Ce / Au-Stomatocytes@CM, IV: Ce / Au-Stomatocytes@CM+Laser);

[0047] Fig.18 The changes in tumor volume of each group of mice during treatment with different methods in Example 15;

[0048] Fig.19 These are photos of tumor-bearing mice in each group after being treated with different methods for 14 days in Example 15;

[0049] Fig. 20 This is the H&E staining analysis of the skin outside the tumor after 14 days of treatment with different methods in Example 15;

[0050] Fig.21 The expression of cytokines in the serum of mice after 14 days of treatment with different methods in Example 15. DETAILED DESCRIPTION

[0051] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0052] Unless otherwise specified, all chemical reagents were used directly without further purification. mPEG-OH was purchased from JenKem Technology (Beijing, China). SOD enzyme kit, chloroauric acid, polyacrylic acid, and sodium borohydride were purchased from Sigma-Aldrich (St. Louis, MO). Ce nitrate hexahydrate, IL-6, and TNF-α ELISA kits were purchased from Thermo Fisher Scientific (Waltham, MA). 4T1 cells (mouse breast cancer cell line) and RAW 264.7 cells (mouse macrophage cell line) were from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. DMEM medium, penicillin-streptomycin double antibody, and trypsin were purchased from Hangzhou Gino Biomedical Technology Co., Ltd. (Hangzhou, China). Fetal bovine serum was purchased from Gibco Life Technologies Co., Ltd. (Carlsbad, CA). Cell Counting Kit-8 (CCK-8) was purchased from Shanghai Qihai Biotechnology Co., Ltd. (Shanghai, China). Cell apoptosis detection kit was purchased from Jiangsu Keygene Biotechnology Co., Ltd. (Jiangsu, China). BALB / c mice were purchased from Shanghai Slack Laboratory Animal Center (Shanghai, China). Cell membrane and membrane protein extraction kits were purchased from Bio-Tech Biotechnology Co., Ltd. (Shanghai, China).

[0053] Example 1

[0054] (1) According to the literature method (Abdelmohsen et al. J. Am. Chem. Soc., 2016, 138(30), 9353-9356), two PEG-PDLLA copolymers (PEG) were synthesized by ring-opening polymerization using methoxypolyethylene glycol hydroxyl (mPEG-OH) and D,L-lactide (DLL) as raw materials. 22 -PDLLA 95 and PEG 44 -PDLLA 95 ). First, 200 mg mPEG(1K)-OH and 2.736 g DLL were co-dissolved in 50 mL of dry toluene and rotary evaporated to remove moisture from the two reagents. Subsequently, the reagents were dissolved again with 38 mL of dry dichloromethane (DCM) and 15 μL of 1,8-diazacyclo[5,4,0]undecene-7 (DBU) under argon protection, and the reaction was stirred for 2 hours. After the reaction, the mixed solution was diluted with DCM, washed twice with 1 M potassium bisulfate solution, washed once with 1 M sodium chloride solution, dried over sodium sulfate, filtered, and rotary evaporated to obtain a copolymer concentrated in the DCM solution. The DCM solution was cold precipitated in pre-cooled ether, centrifuged at 4350 rpm for 6 minutes, the precipitate was collected and redissolved in dioxane, and lyophilized to obtain PEG. 22-PDLLA 95 PEG was synthesized using the same method 44 -PDLLA 95 The raw materials used were: 200 mg mPEG(2K)-OH, 2.736 g DLL, 19 mL dry DCM and 7.5 μL DBU. 22 -PDLLA 95 and 5mg PEG 44 -PDLLA 95 Dissolve in 1mL of tetrahydrofuran / dioxane mixed solution (1:4, v / v), seal and stir at 900rpm for 30min. After mixing evenly, add 1mL of water dropwise to the mixed solution at a rate of 1mL / h through a syringe pump to obtain a turbid suspension. After the reaction is completed, the suspension is dialyzed (4°C) in a precooled sodium chloride solution (50mM) using a dialysis bag with a molecular weight cutoff of 12-14kDa. The sodium chloride solution is replaced after 1h, and the dialysis is continued for 24h to obtain a bowl-shaped polymer vesicle (Stomatocytes) dispersion.

[0055] (2) According to the literature method (Asati et al. Angew. Chem., Int. Ed., 2009, 48 (13), 2308-2312), cerium oxide nanoparticles (CeO2 NPs) were synthesized using cerium nitrate hexahydrate as a reaction precursor and ammonia water as a precipitant, and further surface-modified with polyacrylic acid to improve stability. Briefly, 5 mL of cerium nitrate hexahydrate aqueous solution (1M) was prepared, added to 10 mL of PAA aqueous solution (0.5M), stirred evenly, and then added dropwise to 30 mL of 30% ammonia water, and stirred for 24 hours. After the reaction was completed, the mixed solution was centrifuged at 4000 rpm for 30 minutes, repeated 3 times, and large particle precipitation was removed. Finally, an ultrafiltration tube with a molecular weight cutoff of 10K was used to centrifuge at 4000 rpm for 30 minutes to remove excess PAA, and CeO2 NPs were obtained. 2 mg CeO2NPs were dispersed in 500 μL water, added dropwise to 1 mL Stomatocytes dispersion (1 mg / mL), and stirred at 500 rpm for 24 h. After the reaction, the unloaded CeO2NPs in the supernatant were removed by centrifugation at 6000 rpm for 6 min, and Stomatocytes (Ce-Stomatocytes) loaded with CeO2 NPs were obtained in the precipitate. The Ce content in Ce-Stomatocytes was measured and calculated by ammonium ferrous sulfate titration (Wang et al. Biomolecules, 2022, 12 (9), 1277).

[0056] 0.8 mg polyacrylic acid and 1.2 μL chloroauric acid (1 mg / mL) were added to 1 mL Ce-Stomatocytes dispersion (3.33 mg / mL), stirred at 200 rpm for 10 min to mix the reaction materials evenly. Subsequently, 1 mL sodium borohydride solution (5 mM) was added dropwise to the mixed solution, and the reaction was continued to stir at 200 rpm for 10 min. After the reaction was completed, centrifuged at 7000 rpm for 10 min, and water was added to resuspend after removing the supernatant, and centrifuged again. This process was repeated three times to remove the Au NPs not loaded in the supernatant. Finally, the centrifuged precipitate was dispersed in 1 mL water to obtain Stomatocytes (Ce / Au-Stomatocytes) loaded with CeO2 NPs and Au NPs. The content of Au in Ce / Au-Stomatocytes was measured by an inductively coupled plasma emission spectrometer (ICP-OES).

[0057] Example 2

[0058] The size and morphology of the Stomatocytes, Ce-Stomatocytes, Ce / Au-Stomatocytes prepared in Example 1 and the Polymersomes prepared in Comparative Example 1 were characterized. Figure 2 As shown in A, the hydrodynamic diameter of the synthesized Polymersomes is 350nm. The Polymersomes were dialyzed with a precooled sodium chloride solution (50mM). The change in osmotic pressure can cause the Polymersomes to deform, and the hydrodynamic diameter of the formed Stomatocytes is 333nm ( Figure 2 B) From Figure 2 The cryo-TEM image shown in C clearly shows the opening / neck of the Stomatocytes, proving that the synthesized Stomatocytes have an asymmetric structure. After loading CeO2NPs, the hydrodynamic diameter of Ce-Stomatocytes increased to 377nm ( Figure 3 A), and nanoparticles can be observed in the internal cavity of stomatocytes ( Figure 3 BC), indicating that CeO2NPs were successfully loaded into the internal cavity of Stomatocytes. After further deposition of AuNPs on the surface of Ce-Stomatocytes, the hydrodynamic diameter of Ce / Au-Stomatocytes increased to 430nm ( Figure 3 D), and a layer of small nanoparticles can be observed on the surface of Stomatocytes ( Figure 3 EF), AuNPs synthesized by surface in situ reduction were deposited on the surface of stomatocytes.

[0059] Example 3

[0060] The catalase (CAT)-like activity of CeO2 NPs can catalyze the decomposition of H2O2 to produce O2. Therefore, the CAT-like enzyme activity of the prepared CeO2NPs and Ce-containing Stomatocytes can be verified by detecting the production of O2 or the decomposition of H2O2. First, the Ce-Stomatocytes, Ce / Au-Stomatocytes and CeO2 NPs prepared in Example 1 were dispersed in 100 μM H2O2 solution ([Ce] = 5 mg / mL) and placed in EP tubes. Photos were taken at different time points to record the generation of O2 bubbles in each tube. Figure 4 As shown in A, bubbles gradually appeared in the three EP tubes from 0 min to 30 min, proving that CeO2 NPs and Ce-containing Stomatocytes can catalyze the decomposition of H2O2 to produce O2 under the action of Ce.

[0061] Subsequently, the CAT-like enzyme activity of Ce / Au-Stomatocytes under different conditions was further analyzed by detecting the changes in the ultraviolet absorbance of H2O2 at 240nm. Ce-Stomatocytes, Ce / Au-Stomatocytes and CeO2 NPs were dispersed in H2O2 solutions of different concentrations (0, 0.01, 0.1, 1 and 10mM, [Ce] = 5mg / mL), and the ultraviolet absorbance of each dispersion at 240nm was immediately detected. After incubation for 10 minutes, the ultraviolet absorbance of each dispersion at 240nm was detected again, and the reduction in the ultraviolet absorbance of each dispersion at 240nm before and after incubation was calculated, and this was used to analyze the degradation of H2O2. Figure 4 As shown in Figure B, CeO2 NPs and Ce-containing Stomatocytes can reduce the UV absorbance of H2O2 at 240nm, and the UV absorbance reduction value gradually increases with the increase of H2O2 concentration. These results once again prove that Ce has CAT enzyme activity and Ce-loaded Stomatocytes can decompose H2O2 of different concentrations.

[0062] To analyze the CAT-like enzyme activity of Ce / Au-Stomatocytes at different Ce concentrations, Ce / Au-Stomatocytes with different Ce concentrations were dispersed in 100 μM H2O2 solutions ([Ce] = 0.2, 0.4, 1, 2 and 4 mg / mL), and the UV absorbance of each dispersion at 240 nm was immediately detected. After incubation for different time periods (0-15 min), the UV absorbance of each dispersion at 240 nm was detected again, and the decrease in UV absorbance of each dispersion at 240 nm before and after incubation was calculated. The results are shown in Figure 2. Figure 5 As shown in A, the CAT-like enzyme activity of Ce / Au-Stomatocytes showed Ce concentration dependence, and higher Ce concentrations could catalyze more and faster decomposition of H2O2.

[0063] To analyze the CAT-like enzyme activity of Ce / Au-Stomatocytes at different pH, Ce / Au-Stomatocytes were dispersed in H2O2 solutions of different pH (pH = 3, 4, 5, 6, 7, 8 and 9, [Ce] = 2 mg / mL, [H2O2] = 100 μM), and the UV absorbance of each dispersion at 240 nm was immediately detected. After incubation for 10 minutes, the UV absorbance of each dispersion at 240 nm was detected again, and the decrease in UV absorbance of each dispersion at 240 nm before and after incubation was calculated. The results are shown in Figure 2. Figure 5 As shown in B, the CAT-like enzyme activity of Ce / Au-Stomatocytes gradually increases with the increase of pH in the pH range of 5-8. It is worth noting that although the CAT-like enzyme activity of Ce / Au-Stomatocytes is stronger in alkaline pH, it also has a relatively stable catalytic activity at pH 5-6, which indicates that Ce / Au-Stomatocytes are also capable of catalyzing the decomposition of H2O2 in slightly acidic TME.

[0064] Finally, using Red H2O2 detection kit, according to the instructions, detects CAT-like enzyme activity of Ce / Au-Stomatocytes ([Ce] = 2 mg / mL) at different temperatures (room temperature (RT), 37°C, 45°C and 60°C). Figure 5 As shown in Figure C, the decomposition of H2O2 increased significantly when the temperature was increased to 45°C, indicating that Ce / Au-Stomatocytes may have stronger CAT-like enzyme activity in the warm TME after photothermal treatment.

[0065] Example 4

[0066] The superoxide dismutase (SOD)-like activity of CeO2 NPs can catalyze the degradation of superoxide anions (O2- ) undergoes dismutation to produce H2O2. Using a SOD enzyme activity detection kit (Sigma-Aldrich), according to the instructions, the SOD-like enzyme activity of Ce-Stomatocytes, Ce / Au-Stomatocytes, CeO2 NPs prepared in Example 1 and Au-Stomatocytes prepared in Comparative Example 2 was detected ([Ce] = 2 mg / mL, the concentration of Au-Stomatocytes without Ce was consistent with the concentration of Ce-containing samples) or the SOD-like enzyme activity of Ce / Au-Stomatocytes under different conditions, including different Ce concentrations (0.2, 0.4, 1, 2 and 4 mg / mL), different pH (3, 4, 5, 6, 7, 8 and 9, [Ce] = 2 mg / mL) and different temperatures (37°C, 45°C and 60°C, [Ce] = 2 mg / mL). Figure 6 As shown in A, Ce-Stomatocytes have strong SOD-like enzyme activity due to the loading of CeO2 NPs. Au-Stomatocytes loaded with Au NPs only also showed about 20% SOD-like enzyme activity, which may be due to the fact that Au NPs also have a certain SOD-like enzyme activity. Under the combined action of Ce and Au, the SOD-like enzyme activity of Ce / Au-Stomatocytes further increased to about 60%.

[0067] Subsequently, the SOD-like enzyme activity of Ce / Au-Stomatocytes under different conditions was analyzed. First, the SOD-like enzyme activity of Ce / Au-Stomatocytes showed Ce concentration dependence. As the Ce concentration increased from 0.2 mg / mL to 4 mg / mL, its SOD-like enzyme activity gradually increased to nearly 80% ( Figure 6 B). Secondly, the SOD-like enzyme activity of Ce / Au-Stomatocytes first increased and then decreased with the increase of pH, and showed higher enzyme-like activity in slightly acidic pH (pH 5-6) ( Figure 6 C). In addition, the SOD-like enzyme activity of Ce / Au-Stomatocytes remained at a high level at different temperatures ( Figure 6 D). The above experimental results indicate that Ce / Au-Stomatocytes will have stable SOD-like enzyme activity in the warm TME after photothermal treatment.

[0068] Example 5

[0069] CeO2 NPs also have the ability to scavenge reactive oxygen species (ROS). Taking hydroxyl radicals (·OH) as the representative of ROS, the scavenging efficiency of different samples on ROS was detected. First, ferrous sulfate was mixed with H2O2 solution to produce hydroxyl radicals (·OH) through the Fenton reaction. Subsequently, salicylic acid and different samples were added. Salicylic acid can react with ·OH to produce 2,3-dihydroxybenzoic acid, while the addition of samples can inhibit the formation of 2,3-dihydroxybenzoic acid by consuming ·OH. Since 2,3-dihydroxybenzoic acid has characteristic ultraviolet absorption at 510nm, the scavenging efficiency of the sample on ·OH can be indirectly reflected by detecting the change in ultraviolet absorbance at 510nm. According to this method, the ROS scavenging efficiency of Ce-Stomatocytes, Ce / Au-Stomatocytes, CeO2 NPs prepared in Example 1 and Au-Stomatocytes prepared in Comparative Example 2 ([Ce] = 2 mg / mL, the concentration of Au-Stomatocytes without Ce is consistent with the concentration of Ce-containing samples) or the ROS scavenging efficiency of Ce / Au-Stomatocytes under different conditions, including different Ce concentrations (0.2, 0.4, 1, 2 and 4 mg / mL) and different temperatures (37°C, 45°C and 60°C, [Ce] = 2 mg / mL) was detected. First, Ce-Stomatocytes and Ce / Au-Stomatocytes loaded with CeO2 NPs can remove about 40% of ·OH ( Figure 7 A). When the Ce concentration in Ce / Au-Stomatocytes gradually increased, the scavenging efficiency of Ce / Au-Stomatocytes for ·OH also gradually increased, indicating that the scavenging efficiency of Ce / Au-Stomatocytes for ROS is concentration-dependent ( Figure 7 B). In addition, the ROS scavenging efficiency of Ce / Au-Stomatocytes first increased and then decreased with the increase of temperature, and reached the highest value at 45°C ( Figure 7 C). The above experimental results prove that Ce / Au-Stomatocytes have good ·OH scavenging performance.

[0070] In general, the prepared Ce / Au-Stomatocytes can utilize the enzyme-like activity of Ce to remove ROS and convert O2· - It is converted into H2O2 and further decomposes H2O2 to produce O2, so it is expected to relieve hypoxia and regulate the level of inflammation in the TME after PTT, thereby enhancing the therapeutic effect.

[0071] Example 6

[0072] The Ce / Au-Stomatocytes prepared in Example 1 were taken to characterize their photothermal heating performance. 0.5 mL of Ce / Au-Stomatocytes dispersions of different concentrations (0.3, 0.6, 1, 1.5 and 3 mg / mL) were placed in a 1.5 mL EP tube, and 0.5 mL of water (MilliQ H2O) and Ce-Stomatocytes (3 mg / mL) dispersions were used as controls. Each EP tube was irradiated for 10 min with a 660 nm laser (1.5 W). During the irradiation period, the temperature of the dispersion in the tube was recorded by a thermometer (Chauvin Arnoux, CA 1823), and the photothermal heating curve was drawn. Subsequently, the photothermal heating curve of Ce / Au-Stomatocytes dispersion (3 mg / mL) under laser irradiation of different powers (0, 0.75, 1, 1.2 and 1.5 W) was detected in the same way. In addition, the photothermal stability of Ce / Au-Stomatocytes (3 mg / mL) was evaluated by repeated heating-cooling experiments. Finally, the photothermal conversion efficiency of Ce / Au-Stomatocytes was calculated according to the literature method (Liu et al. Adv. Mater., 2013, 25 (9), 1353-1359). Under the irradiation of 660nm laser, the temperature of MillQ H2O and Ce-Stomatocytes dispersion did not change significantly, while the temperature of the dispersion containing different concentrations of Ce / Au-Stomatocytes increased significantly, and the heating efficiency increased with the increase of concentration, which indicates that Ce / Au-Stomatocytes mainly use the loaded Au NPs to convert light energy into heat energy ( Figure 8 A). Figure 8 As shown in Figure B, the Ce / Au-Stomatocytes dispersion has a greater temperature rise under the irradiation of a higher power laser, indicating that the photothermal heating efficiency of Ce / Au-Stomatocytes is positively correlated with the laser power. In addition, in at least 5 cycles of laser irradiation, the temperature rise of the Ce / Au-Stomatocytes dispersion within 10 minutes remains stable, indicating that the prepared Ce / Au-Stomatocytes have good photothermal stability ( Figure 8 C). The photothermal conversion efficiency of Ce / Au-Stomatocytes was calculated to be 41.6%.

[0073] Example 7

[0074] The Ce / Au-Stomatocytes prepared in Example 1 were taken to characterize their motion performance driven by H2O2 / laser dual drive, and NanoSight Tracking Analysis (NTA) analysis was performed on a NanosightNS300 (Malvern Panalytical) machine equipped with a 488nm laser, sCMOS camera, and additional inductive coupling accessories and external light source (660nm). First, the motion of Ce / Au-Stomatocytes dispersion (10μg / mL) under irradiation with different power lasers (660nm, 0, 0.5, 0.75, 1, 1.25, 1.5 and 1.75W) was analyzed. Subsequently, Ce / Au-Stomatocytes were dispersed in 100μM or 1mM H2O2 solution, and the motion of Ce / Au-Stomatocytes was analyzed. Finally, Ce / Au-Stomatocytes were dispersed in 100 μM H2O2 solution and their movement was detected under 1.25 or 1.5 W laser irradiation. According to the results of NTA, the X and Y coordinates of at least 25 nanoparticles were tracked within 30 s in each test to analyze their movement trajectory, and the mean squared displacement (MSD) was calculated using a special Python script. Fig. 9 As shown in A, Ce / Au-Stomatocytes can be driven by laser, and the increase in its MSD increases with the increase in laser power, indicating that the movement behavior of Ce / Au-Stomatocytes is positively correlated with the laser power. Further analysis of the movement trajectory of Ce / Au-Stomatocytes revealed that Ce / Au-Stomatocytes perform directional movement in the opposite direction of the light source under laser irradiation ( Fig. 9 D). The movement characteristics of Ce / Au-Stomatocytes under laser irradiation may be due to the fact that the AuNPs deposited on the surface of Stomatocytes can convert light energy into heat energy, thus causing the Stomatocytes to perform thermophoresis. In addition, the asymmetric structure of Stomatocytes causes the deposited AuNPs to be unevenly arranged along the axis of the Stomatocytes, which makes the heat generated by them when irradiated by laser unevenly distributed, thus forming a temperature gradient, causing the Stomatocytes to perform negative phototaxis directional movement.

[0075] Subsequently, the motility of Ce / Au-Stomatocytes in H2O2 solutions of different concentrations was analyzed. Fig. 9As shown in B, the MSD of Ce / Au-Stomatocytes (10 μg / mL) in H2O2 solution is greater than its MSD in water (0 μM). Further analysis of the trajectory revealed that Ce / Au-Stomatocytes performed non-directional movement in 100 μM H2O2 solution ( Fig. 9 E). The movement of Ce / Au-Stomatocytes in H2O2 solution may be due to the fact that Ce can decompose H2O2 to produce O2 in the internal cavity using CAT-like enzyme activity. O2 bubbles overflowing from the inner cavity can drive Stomatocytes, but at this time, the MSD of Ce / Au-Stomatocytes is much smaller than its MSD driven by laser. Finally, the movement ability of Ce / Au-Stomatocytes (10μg / mL) in the presence of H2O2 and laser irradiation was detected. Fig. 9 As shown in C and 9F, Ce / Au-Stomatocytes dispersed in 100 μM H2O2 solution restored the directional movement against the light source under 1.25 W or 1.5 W laser irradiation, which was similar to the MSD when driven by only 1.25 W or 1.5 W laser, indicating that the movement of Ce / Au-Stomatocytes was mainly dominated by the laser in this case.

[0076] After analyzing the movement performance of Ce / Au-Stomatocytes, it was found that Ce / Au-Stomatocytes have the ability to perform non-directional autonomous movement driven by O2 in the TME overexpressing H2O2, thereby promoting the penetration of Ce / Au-Stomatocytes in the tumor to a certain extent. After further laser irradiation of the tumor site, Ce / Au-Stomatocytes can perform relatively fast directional movement, thereby further improving their distribution in the tumor and enhancing the therapeutic effect.

[0077] Example 8

[0078] (1) Collect 1×10 4T1 cells in the logarithmic growth phase 7 The cells were centrifuged at 1000 rpm for 5 min to obtain cell pellets, and cell membranes (cancer cell membranes, CM) were obtained from the 4T1 cell pellets using a cell membrane and membrane protein extraction kit.

[0079] (2) 200 μg of Ce / Au-Stomatocytes were mixed with 0.5 mL of CM suspension, and the solution was extruded 11 times using an Avanti microextruder. The solution was centrifuged at 12,000 rpm for 8 min to remove excess cell membranes to obtain Ce / Au-Stomatocytes@CM.

[0080] Example 9

[0081] The size and morphology of the Ce / Au-Stomatocytes@CM prepared in Example 8 were characterized. Fig.10 The cryo-TEM image shown shows that there is a coating on the surface of the Stomatocytes after encapsulation. In addition, Ce / Au-Stomatocytes@CM still retains the asymmetric appearance of Stomatocytes, indicating that the encapsulation process does not change the structure of Stomatocytes. The Zeta potential and hydrodynamic diameter of Ce / Au-Stomatocytes@CM were further measured and compared with Ce / Au-Stomatocytes. The results are shown in Table 1. The Zeta potential of Stomatocytes after encapsulation decreased from -14.47mV to -20.03mV, while the hydrodynamic diameter increased to 473.50nm, further proving the encapsulation of CM.

[0082] In addition, Ce / Au-Stomatocytes, CM and Ce / Au-Stomatocytes@CM were taken for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) experiments. First, the protein content in CM and Ce / Au-Stomatocytes@CM was determined by BCA protein quantification kit, and the protein content in each sample was adjusted to 0.8 mg / mL with PBS solution. 5 μL of protein marker was added to the first protein lane, and then 15 μL of CM, Ce / Au-Stomatocytes (the concentration was the Ce / Au-Stomatocytes concentration corresponding to the protein concentration of 0.8 mg / mL in Ce / Au-Stomatocytes@CM) and Ce / Au-Stomatocytes@CM were added to the protein lane respectively, and the current was set to 100 A and the time was set to 30 min. Fig.11 As shown, the Ce / Au-Stomatocytes group did not show any protein bands, while the Ce / Au-Stomatocytes@CM group had similar protein bands to the CM group, indicating that the membrane proteins were retained on the surface of Ce / Au-Stomatocytes and also verifying the coating of CM.

[0083] Table 1 Potential, hydrodynamic diameter and polydispersity index of samples before and after cell membrane coating

[0084] sample Zeta potential (mV) Hydrodynamic diameter (nm) Polydispersity index Ce / Au-Stomatocytes -14.47±1.17 430.43±1.50 0.07±0.04 Ce / Au-Stomatocytes@CM -20.03±1.20 473.50±1.71 0.08±0.02

[0085] Example 10

[0086] 4T1 cells were used as a cell model to evaluate the phagocytic ability of cells on Stomatocytes, Ce-Stomatocytes, Ce / Au-Stomatocytes, and the phagocytic ability of cells on Ce / Au-Stomatocytes under laser assistance (Ce / Au-Stomatocytes+Laser). 4T1 cells were cultured at a rate of 1×10 5 The cells were seeded in a 12-well plate at a density of 100 cells per well. The culture medium used was DMEM complete culture medium supplemented with 100 U / mL penicillin, 100 U / mL streptomycin and 10% FBS. The cells were incubated at 5% CO2 and 37°C for 24 hours. The original culture medium was discarded, and the culture medium containing Stomatocytes, Ce-Stomatocytes or Ce / Au-Stomatocytes ([Stomatocytes] = 50 μg / mL, all labeled with Cy5) was added to the cells and co-cultured at 5% CO2 and 37°C for 6 hours. For the Ce / Au-Stomatocytes+Laser group, after adding the fresh culture medium containing Ce / Au-Stomatocytes to the cells, they were immediately irradiated with a 660nm laser (1W) for 5 minutes and then continued to incubate for 6 hours. After that, the cells in the 12-well plate were digested, centrifuged, and resuspended in PBS. The intracellular fluorescence intensity was quantitatively analyzed by flow cytometry to evaluate the phagocytosis of each Stomatocyte. The results are as follows Fig.12 As shown in the figure, compared with Stomatocytes, the fluorescence intensity in Ce-Stomatocytes group was significantly enhanced, which may be due to the CAT enzyme activity of Ce, which enables Ce-Stomatocytes to produce O2 during co-incubation with 4T1 cells, thereby driving Ce-Stomatocytes to enter 4T1 cells through autonomous movement. In addition, laser irradiation enhances the phagocytosis of Ce / Au-Stomatocytes by 4T1 cells, because Ce / Au-Stomatocytes can move in a directional manner under laser irradiation, thereby penetrating the cell membrane and entering the cell.

[0087] Subsequently, 4T1 and B16-F10 cells were used as cell models to evaluate the homologous targeting of CM. 4T1 cells and B16-F10 cells were inoculated in 12-well plates and cultured as described above. Subsequently, culture medium containing Ce / Au-Stomatocytes or Ce / Au-Stomatocytes@CM ([Stomatocytes] = 50 μg / mL, both labeled with Cy5) was added and co-cultured with the cells under 5% CO2 and 37°C for 6 hours. For the Ce / Au-Stomatocytes@CM+Laser group, after adding fresh culture medium containing Ce / Au-Stomatocytes to the cells, they were immediately irradiated with a 660nm laser (1W) for 5 minutes and then incubated for another 6 hours. Afterwards, the cells in the 12-well plate were digested, centrifuged, and resuspended in PBS. The intracellular fluorescence intensity was quantitatively analyzed by flow cytometry to evaluate the phagocytosis of Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM in the two cells. Fig.13 As shown in the figure, the phagocytosis of Ce / Au-Stomatocytes@CM in 4T1 cells was significantly higher than that of Ce / Au-Stomatocytes (p<0.001), while the phagocytosis of Ce / Au-Stomatocytes@CM in B16-F10 cells was slightly different from that of Ce / Au-Stomatocytes, indicating that CM can only promote the phagocytosis of Ce / Au-Stomatocytes in 4T1 cells through homologous targeting, but cannot significantly enhance the phagocytosis of Stomatocytes by B16-F10 cells. In addition, laser irradiation significantly increased the phagocytosis of Ce / Au-Stomatocytes@CM by both cells, further proving that laser can drive Ce / Au-Stomatocytes@CM into cells by driving mechanical movement.

[0088] Embodiment 11

[0089] 4T1 cells were used as a cell model to detect the cytotoxicity of Stomatocytes and CeO2 NPs prepared in Example 1, as well as the cytotoxicity of Ce-Stomatocytes, Ce / Au-Stomatocytes, and Ce / Au-Stomatocytes@CM ([Stomatocytes] = 0, 2.5, 5, 10, 25, 50, 100, 200, and 400 μg / mL) before and after laser irradiation. 4T1 cells in the logarithmic growth phase were collected and 1×10 cells were added to each well. 4Cells were seeded in 96-well plates at a density of 10 cells / mL and incubated at 5% CO2 and 37°C for 24 h. The original culture medium was discarded, and culture medium containing Stomatocytes ([Stomatocytes] = 0, 2.5, 5, 10, 25, 50, 100, 200 and 400 μg / mL), CeO2 NPs ([Ce] = 0, 0.05, 0.1, 0.25, 0.5, 1, 2.5, 5 and 10 mg / mL) or Ce-Stomatocytes, Ce / Au-Stomatocytes, Ce / Au-Stomatocytes@CM ([Stomatocytes] = 0, 2.5, 5, 10, 25, 50, 100, 200 and 400 μg / mL) was added to each well plate and co-cultured with the cells at 5% CO2 and 37°C. After 6 hours, laser irradiation (5 min, 1W) was performed on each well containing Ce-Stomatocytes, Ce / Au-Stomatocytes or Ce / Au-Stomatocytes@CM, and the culture was continued for 18 hours. After that, all wells were taken out, the original culture medium was discarded, and the plates were washed three times with PBS. Fresh culture medium containing 10% (v / v) CCK-8 was added, and the plates were incubated in the incubator for another 3 hours. Finally, the absorbance of each well was tested at a wavelength of 450nm using a multifunctional microplate reader, and the cells co-incubated with Ce-Stomatocytes, Ce / Au-Stomatocytes or Ce / Au-Stomatocytes@CM but not irradiated with laser were used as controls. The results are shown in Figure 2. Fig.14 As shown in A, Stomatocytes without NPs loading have good cytocompatibility, and at high concentrations, the cell viability of 4T1 cells is still maintained above 95%. Although higher concentrations of CeO2 NPs will inhibit the cell viability of 4T1 cells to a certain extent, they have good cytocompatibility at relatively low concentrations (<2.5 mg / mL) ( Fig.14 B). Ce-Stomatocytes, Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM alone did not significantly affect the cell viability of 4T1 cells, but after laser irradiation, the cell viability of Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM groups decreased significantly with increasing concentrations ( Fig.14C). This indicates that the laser can trigger the photothermal properties of Au NPs, causing them to convert light energy into heat energy in 4T1 cells, thereby performing PTT to inhibit cancer cell viability. In addition, after laser irradiation, the downward trend of cell viability in the Ce / Au-Stomatocytes@CM group was stronger than that in the Ce / Au-Stomatocytes group. This is because the coating of CM enables 4T1 cells to engulf more Ce / Au-Stomatocytes@CM, thereby generating more heat in the cells to inhibit cell viability.

[0090] Example 12

[0091] 4T1 cells were used as a cell model to evaluate the efficiency of different stomatocytes and laser-induced apoptosis. 4T1 cells were cultured at a rate of 1×10 5 The cells were seeded at a density of 100 cells per well in a 12-well plate. The culture medium used was DMEM complete culture medium supplemented with 100U / mL penicillin, 100U / mL streptomycin and 10% FBS. The cells were incubated at 5% CO2 and 37°C for 24 hours. The original culture medium was discarded, and the culture medium containing Ce-Stomatocytes, Ce / Au-Stomatocytes or Ce / Au-Stomatocytes@CM ([Stomatocytes] = 50μg / mL) was added and co-cultured with the cells at 5% CO2 and 37°C for 6 hours, and then laser irradiated (5min, 1W). After continuing to culture for 6 hours, the cells in the well plate were digested, centrifuged, and collected. The cells were stained with the AnnexinV-FITC / PI apoptosis detection kit, and then the apoptosis of each group of cells was analyzed by flow cytometry, with cells that were not irradiated with laser as the control. Fig.15 As shown in the figure, after laser irradiation, the proportion of apoptotic and necrotic cells in Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM groups loaded with Au NPs increased significantly, and the apoptotic and necrotic rates of 4T1 cells that engulfed more Ce / Au-Stomatocytes@CM were the highest among all groups. This indicates that Ce / Au-Stomatocytes@CM can utilize the photothermal properties of Au NPs to induce cancer cell apoptosis through PTT under laser irradiation.

[0092] Example 13

[0093] A 12-well transwell system (containing a 0.4-μm polycarbonate porous membrane) was used to evaluate the effect of Ce / Au-Stomatocytes@CM-mediated PTT on the expression level of proinflammatory cytokines. 4T1 cells were plated at 1×10 5The cells were seeded at a density of 1×10 cells per well in the upper chamber of the tranwell system and incubated overnight at 5% CO2 and 37°C. 5 The density of cells was inoculated in the lower chamber of the tranwell system and cultured. Afterwards, the original culture medium of 4T1 cells was removed, and culture medium containing Stomatocytes, CeO2 NPs, Ce-Stomatocytes, Au-Stomatocytes, Ce / Au-Stomatocytes or Ce / Au-Stomatocytes@CM was added ([Stomatocytes] = 50 μg / mL, the concentration of CeO2 NPs was consistent with the concentration of the sample containing Stomatocytes) and the cells were co-cultured for 6 hours under 5% CO2 and 37°C. Laser irradiation (5 min, 1 W) was then performed, and the RAW264.7 cells in the upper and lower chambers were mixed and cultured for another 18 hours. Afterwards, the culture medium in each well was collected, and the expression levels of two representative pro-inflammatory factors (IL-6 and TNF-α) were detected by ELISA kits. Cells without laser irradiation were used as controls. The results are shown in Figure 2. Fig.16 As shown. Without the use of laser, the expression of the two pro-inflammatory factors in the Stomatocytes and Au-Stomatocytes groups increased to varying degrees compared with the PBS group, while CeO2 NPs and Ce-Stomatocytes inhibited the expression of the two pro-inflammatory factors. Under the action of Ce, the expression levels of the two pro-inflammatory factors in the Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM groups were similar to those in the PBS group, and lower than those in the Au-Stomatocytes group without Ce. After laser irradiation, the expression levels of IL-6 and TNF-α in the Au-Stomatocytes group increased significantly due to the apoptosis and necrosis of cancer cells induced by PTT. On the contrary, the expression levels of the two cytokines in the Ce / Au-Stomatocytes and Ce / Au-Stomatocytes@CM groups were reasonably regulated and significantly lower than those in the Au-Stomatocytes group. These experimental results indicate that Ce has anti-inflammatory activity, and Stomatocytes loaded with Ce can regulate the level of inflammation and inhibit the expression level of pro-inflammatory factors after PTT.

[0094] Embodiment 14

[0095] The tumor targeting and motion-enhanced tumor penetration of Ce / Au-Stomatocytes@CM were verified by fluorescence imaging in tumor-bearing mice. All animal experiments were conducted in strict accordance with the standards of the Animal Protection Association (the animal ethics review has been approved by the Science and Technology Ethics Committee of Donghua University). The 6-week-old female BALB / c mice used in the experiment were purchased from Shanghai Slake Laboratory Animal Center (Shanghai, China). 6 4T1 cells were inoculated into the right hind leg of healthy BALB / c mice to construct a 4T1 subcutaneous tumor model in mice. When the tumor volume reached about 200 mm 3 At the same time, tumor-bearing mice were randomly divided into 4 groups for in vivo fluorescence imaging, and the specific groups were as follows: Au-Stomatocytes, Ce / Au-Stomatocytes, Ce / Au-Stomatocytes@CM, and Ce / Au-Stomatocytes@CM+Laser ([Stomatocytes] = 25 mg / kg, dispersed in 100 μL PBS, all labeled with Cy5), and the injection method was tail vein injection. The in vivo fluorescence distribution of mice was recorded by an in vivo fluorescence imaging system (IVIS Lumina series III, Caliper Lifescience Co., Hopkinton, MA) at different time points after injection (0, 15, 45, 90, 120 min). After the imaging, the mice in each group were euthanized and the main organs (heart, liver, spleen, lung, kidney) and tumors were collected for ex vivo fluorescence imaging to analyze the in vivo biodistribution of different Stomatocytes. For the Ce / Au-Stomatocytes@CM+Laser group, the injection method was the same as that of Ce / Au-Stomatocytes@CM, except that the tumor site was additionally irradiated with laser (7 min, 1 W) 90 min after the tail vein injection of Ce / Au-Stomatocytes@CM. Fig.17As shown in A, after Au-Stomatocytes, Au-Stomatocytes@CM or Ce / Au-Stomatocytes@CM were injected via the tail vein, the fluorescence intensity of the mouse tumor site reached a peak 90 minutes after injection, and then weakened with time. The encapsulated Au-Stomatocytes@CM and Ce / Au-Stomatocytes@CM showed enhanced fluorescence signals in the tumor area due to the homologous targeting conferred by CM. To further verify the effect of laser irradiation-driven movement on the distribution of Ce / Au-Stomatocytes@CM in the tumor, the tumor site was laser irradiated 90 minutes after the injection of Ce / Au-Stomatocytes@CM (the laser direction was from the inside of the tumor to the outside). The results showed that the fluorescence signal of the tumor site in the Ce / Au-Stomatocytes@CM+Laser group was slightly stronger than that of Ce / Au-Stomatocytes@CM, and was mainly concentrated on the outside of the tumor, which may be due to the directional mechanical movement triggered by the laser that can help Stomatocytes penetrate into the tumor. Quantitative analysis of the fluorescence intensity in the tumor area once again demonstrated that the encapsulated Stomatocytes accumulated more in the tumor site of mice ( Fig.17 C). It is worth noting that 120 minutes after injection, the fluorescence intensity of the tumor area in the Ce / Au-Stomatocytes@CM+Laser group was significantly higher than that in the Ce / Au-Stomatocytes@CM group (p<0.05), which may be because the laser enables Ce / Au-Stomatocytes@CM to move to the deep layer of the tumor, thereby prolonging its residence time at the tumor site.

[0096] 120 min after tail vein injection, the main organs and tumors of mice in each group were removed for in vitro fluorescence imaging and quantitative analysis. Fig.17As shown in Figures B and 17D, compared with Au-Stomatocytes, the accumulation of Au-Stomatocytes@CM and Ce / Au-Stomatocytes@CM in the liver and lungs was reduced, while the accumulation in the tumor site was significantly increased, further proving the tumor targeting of CM. Observing the distribution of fluorescence signals in tumor tissues of each group, it can be found that the fluorescence signals of Au-Stomatocytes and Au-Stomatocytes@CM groups only covered a small part of the tumor tissue, while the entire tumor tissue of Ce / Au-Stomatocytes@CM group showed fluorescence signals, which may be due to the fact that Ce / Au-Stomatocytes@CM can be driven by O2 generated by Ce catalysis and diffuse in the tumor through autonomous movement. The fluorescence signal distribution in the tumor tissue of Ce / Au-Stomatocytes@CM+Laser group was more uniform, indicating that the directional movement induced by laser irradiation can further help Ce / Au-Stomatocytes@CM penetrate the tumor. These results verified the positive impact of the motility properties of Ce / Au-Stomatocytes@CM on their tumor penetration.

[0097] Embodiment 15

[0098] A mouse subcutaneous tumor model was constructed to verify the in vivo anti-tumor activity of different stomatocytes. 6 4T1 cells were inoculated into the right hind leg of the mouse, and the tumor was inoculated when the volume reached about 100 mm. 3 When the mice were about 10 minutes old, they were randomly divided into 6 groups (6 mice in each group). The specific groups were as follows: PBS, PBS+Laser, Au-Stomatocytes@CM, Au-Stomatocytes@CM+Laser, Ce / Au-Stomatocytes@CM and Ce / Au-Stomatocytes@CM+Laser ([Stomatocytes]=25mg / kg, 0.1mL), and the injection method was tail vein injection. For the three groups that required laser irradiation, 90 minutes after the tail vein injection, the tumor was irradiated with laser for 7 minutes (1W). During the treatment, the treatment was performed once every other day (a total of 4 times), and the mouse weight and tumor volume were recorded once, which lasted until the 14th day. The length of the mouse tumor was recorded as L, and the width was recorded as W, then the tumor volume was (L×W 2 ) / 2. After the treatment, the mice in each group were euthanized on the 14th day, and the tumor size of each group was recorded. Subsequently, the skin tissue outside the tumor of each group of mice was collected, fixed, embedded, sliced, and H&E stained to analyze the damage of the laser to the mouse skin. Finally, on the 14th day, the expression levels of pro-inflammatory cytokines (IL-6 and TNF-α) in the serum of each group of mice were analyzed using ELISA kits. Fig.18 As shown in the figure, the tumor volume of mice in each group increased to varying degrees during the treatment period, and the tumor volume of mice in the Au-Stomatocytes@CM+Laser and Ce / Au-Stomatocytes@CM+Laser groups was significantly smaller than that in the other four groups, indicating that Stomatocytes loaded with Au NPs can ablate tumors through PTT under the action of laser. It is worth noting that Ce / Au-Stomatocytes@CM+Laser has a better inhibitory effect on tumors than Au-Stomatocytes@CM+Laser, which may be because Ce / Au-Stomatocytes@CM can use the loaded CeO2 NPs to produce O2 in the TME, thereby alleviating tumor hypoxia and enhancing the efficacy of PTT. After the treatment, the photos of tumor-bearing mice in each group were observed and it was found that the Au-Stomatocytes@CM+Laser group had severe damage to the skin outside the tumor and scabs due to the high temperature generated during the PTT process, while the damage to the skin outside the tumor in the Ce / Au-Stomatocytes@CM+Laser group with the same PTT effect was significantly reduced ( Fig.19 ). H&E sections were taken on the skin outside the tumors in each group, and the results showed that the glands in the dermis of the Au-Stomatocytes@CM+Laser group were reduced and the infiltration of inflammatory cells was significantly increased ( Fig. 20 In contrast, no obvious inflammatory cell infiltration was observed in the skin sections of the Ce / Au-Stomatocytes@CM+Laser group, indicating that the addition of Ce alleviated the inflammatory response caused by PTT, which will be beneficial to the healing of skin wounds after PTT. It is worth noting that there were also small scab wounds under the tumors of mice in the PBS, Au-Stomatocytes@CM and Ce / Au-Stomatocytes@CM groups. This was caused by the pinholes left after the subcutaneous injection of tumor cells when constructing the tumor model, and was not caused by PTT.

[0099] Finally, the expression levels of two pro-inflammatory factors (IL-6 and TNF-α) in the serum of each group of mice were detected. Fig.21 As shown in the figure, the expression levels of these two cytokines in the serum of mice in the Au-Stomatocytes@CM+Laser group were the highest, indicating that AuNPs-mediated PTT caused a severe inflammatory response in mice at this time, which was consistent with the results of tumor skin damage and skin H&E sections. After adding Ce, the expression levels of both factors in the Ce / Au-Stomatocytes@CM+Laser group were significantly reduced, which once again verified the anti-inflammatory activity of Ce.

[0100] In general, the constructed Ce / Au-Stomatocytes@CM can actively target the tumor area, and then penetrate into the deep layer of the tumor with the assistance of laser, effectively inhibiting tumor growth through PTT. At the same time, Ce / Au-Stomatocytes@CM can also use Ce to relieve tumor hypoxia and inhibit inflammation in TME, thereby further enhancing the efficacy of PTT and alleviating skin damage caused by PTT.

[0101] Comparative Example 1

[0102] 5 mg PEG 22 -PDLLA 95 and 5 mg PEG 44 -PDLLA 95 Dissolve in 1 mL of a mixed solution of tetrahydrofuran and dioxane (1:4, v / v), seal and stir at 900 rpm for 30 min to mix evenly. Subsequently, 1 mL of water was added dropwise to the mixed solution at a rate of 1 mL / h through a syringe pump to obtain a turbid suspension. After the reaction, the suspension was dialyzed in ultrapure water (4°C) using a dialysis bag with a molecular weight cutoff of 12-14 kDa, and ultrapure water was replaced after 1 hour, and the dialysis was continued for 24 hours to obtain a Polymersomes dispersion.

[0103] Comparative Example 2

[0104] (1) 0.8 mg of polyacrylic acid and 1.2 μL of chloroauric acid (1 mg / mL) were added to 1 mL of the dispersion of Stomatocytes prepared in Example 1 (3.33 mg / mL), mixed evenly, and then 1 mL of sodium borohydride solution (5 mM) was added dropwise, and the reaction was continued by stirring. After the reaction was completed, the unloaded Au NPs in the supernatant were removed, and Stomatocytes loaded with Au NPs (Au-Stomatocytes) were obtained in the precipitate.

[0105] (2) According to the experimental method in Example 8, CM was coated on the surface of Au-Stomatocytes to obtain Au-Stomatocytes@CM.

[0106] Comparative Example 3

[0107] 0.01 mg Cy5-DBCO and 5 mg PEG 22 -PDLLA 95 , 5mg PEG 44 -PDLLA 95Dissolved in 1 mL of a mixed solution of tetrahydrofuran and dioxane (1:4, v / v), mixed evenly, and 1 mL of water was added dropwise to the mixed solution at a rate of 1 mL / h. After the reaction was completed, the suspension was dialyzed (4°C) in a precooled sodium chloride solution (50 mM) using a dialysis bag with a molecular weight cutoff of 12-14 kDa, and the sodium chloride solution was replaced after 1 hour, and the dialysis was continued for 24 hours to obtain Cy5-labeled Stomatocytes. According to the experimental method in Example 1, Cy5-labeled Stomatocytes were used as reaction raw materials to load CeO2 NPs and Au NPs to prepare Cy5-labeled Ce / Au-Stomatocytes for subsequent cell and animal experiments. In addition, according to the experimental method in Example 8, CM was coated on the surface of Cy5-labeled Ce / Au-Stomatocytes to obtain Cy5-labeled Ce / Au-Stomatocytes@CM.

Claims

1. A nanomotor composite material, characterized in that: The nanomotor is a polymer vesicle loaded with cerium dioxide nanoparticles / gold nanoparticles, or a polymer vesicle loaded with cerium dioxide nanoparticles / gold nanoparticles and coated with a cell membrane.

2. The nanomotor composite material according to claim 1, characterized in that: The polymer vesicle is a bowl-shaped polymer vesicle; the cell membrane is the cell membrane of breast cancer 4T1 cells.

3. A method for preparing a nanomotor composite material, comprising: (1) The copolymer PEG 22 -PDLLA 95 PEG 44 -PDLLA 95 , and an organic solvent, then dropwise add water and dialyze to obtain a polymer vesicle Stomatocytes dispersion; (2) adding the cerium dioxide nanoparticle dispersion dropwise into the stomatocytes dispersion, stirring for reaction, and centrifuging to obtain a polymer vesicle Ce-Stomatocytes dispersion loaded with cerium dioxide nanoparticles; (3) uniformly mixing chloroauric acid, polyacrylic acid and Ce-Stomatocytes dispersion, dropping a reducing agent, stirring for reaction, and centrifuging to obtain polymer vesicles Ce / Au-Stomatocytes loaded with cerium dioxide nanoparticles / gold nanoparticles; (4) or the Ce / Au-Stomatocytes dispersion of step (3) is evenly mixed with the cell membrane suspension, extruded, and centrifuged to obtain cell membrane-coated polymer vesicles loaded with cerium dioxide nanoparticles / gold nanoparticles.

4. The preparation method according to claim 3, characterized in that: In the step (1), the copolymer PEG 22 -PDLLA 95 and PEG 44 -PDLLA 95 It is obtained by ring-opening polymerization using methoxypolyethylene glycol hydroxyl mPEG-OH and D,L-lactide DLL as raw materials.

5. The preparation method according to claim 3, characterized in that: In the step (1), PEG 22 -PDLLA 95 PEG 44 -PDLLA 95 , the ratio of the organic solvent is 1 mg: 0.9 mg: 0.1 mL to 1 mg: 1.1 mg: 0.3 mL; the organic solvent is a mixed solution of tetrahydrofuran and dioxane; the volume ratio of tetrahydrofuran and dioxane is 1:3 to 1:5; the volume ratio of the organic solvent to water is 1:0.5 to 1:1.5; the rate of adding water is 0.5 to 1.5 mL / h.

6. The preparation method according to claim 3, characterized in that: The dialysis in step (1) is performed in a precooled sodium chloride solution using a dialysis bag with a molecular weight cutoff of 12-14 kDa, the sodium chloride solution is replaced after 0.5-1.5 hours, and the dialysis is continued for 20-25 hours; wherein the concentration of the sodium chloride solution is 45-55 mM; and the dialysis temperature is 3-5°C.

7. The preparation method according to claim 3, characterized in that: In the step (2), the mass ratio of cerium dioxide nanoparticles to stomatocytes is 2:0.5 to 2:1.5; the stirring reaction time is 20 to 25 hours; the centrifugation parameters are: centrifugation at 5500 to 6500 rpm for 5 to 10 minutes, and removing the supernatant.

8. The preparation method according to claim 3, characterized in that: In the step (3), the mass ratio of polyacrylic acid, chloroauric acid and Ce-Stomatocytes is 0.24:0.00035:0.9-0.24:0.00037:1.1; the reducing agent is a sodium borohydride solution with a concentration of 4-6 mM, and the volume ratio of the Ce-Stomatocytes dispersion to the sodium borohydride solution is 1:0.5-1:1.5; the stirring reaction time is 5-15 min; the centrifugation parameters are: centrifugation at 6500-7500 rpm for 5-15 min, and removing the supernatant.

9. The preparation method according to claim 3, characterized in that: In the step (4), the ratio of Ce / Au-Stomatocytes to cell membrane suspension is 200 μg:0.4 mL to 200 μg:0.6 mL; the cell membrane is the cell membrane of breast cancer 4T1 cells; The specific process of the extrusion is: using an Avanti micro extruder with a filter membrane pore size of 700-900nm to repeatedly extrude 10-12 times.

10. Use of the nanomotor composite material according to claim 1 in preparing motion-enhanced tumor photothermal therapy drugs.

Citation Information

Cited By

  • Preparation method of cell membrane camouflage light-driven nano motor

    CN121489904A